Response to warfarin treatment in oral anticoagulation polyclinic patients.
DOI:
https://doi.org/10.35954/SM2000.22.1.4Keywords:
Anticoagulation; Embolism; Thrombosis; Warfarin.Abstract
The purpose of the following article is to consider some generalities of therapy with oral anticoagulants, the importance of the response to treatment with warfarin in patients of the oral anticoagulation polyclinic, as well as the presentation of a study carried out in the Clinical Analysis Laboratory of the Military Hospital with the collaboration of the oral anticoagulation polyclinic, with the aim of determining the average dose of warfarin necessary to maintain an INR between 2 and 3 in patients of the oral anticoagulation polyclinic. In each patient, the dose at which the INR is stabilized between 2 and 3, the recommended value to obtain adequate anticoagulation, was selected. The most commonly used doses are 35 mg and 25 mg, and 75% of the patients require doses lower than 35 mg.
Downloads
Metrics
References
(1) Kordich, Sánchez Avalos. Manual de Hemostasis y Trombosis (Grupo CLAHT). 2ª Ed. Argentina, 1990.
(2) Poller l, Thomson. Thrombosis and its management, 1998.
(3) Reussi, Altman. La terapéutica anticoagulante, 1998.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
